{"id":"https://openalex.org/W2145517536","doi":"https://doi.org/10.1158/2159-8290.cd-11-0249","title":"PI3K\u03b4 Inhibitors in Cancer: Rationale and Serendipity Merge in the Clinic","display_name":"PI3K\u03b4 Inhibitors in Cancer: Rationale and Serendipity Merge in the Clinic","alternate_titles":[],"publication_year":2011,"publication_date":"2011-12-01","ids":{"openalex":"https://openalex.org/W2145517536","doi":"https://doi.org/10.1158/2159-8290.cd-11-0249","mag":"2145517536","pmid":"https://pubmed.ncbi.nlm.nih.gov/22586681"},"language":"en","primary_location":{"id":"doi:10.1158/2159-8290.cd-11-0249","doi":"https://doi.org/10.1158/2159-8290.cd-11-0249","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2159-8290.cd-11-0249","pdf_url":null,"source":{"id":"https://openalex.org/S2486275289","display_name":"Cancer Discovery","issn_l":"2159-8274","issn":["2159-8274","2159-8290"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Discovery","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2145517536"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"David A. Fruman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Fruman","raw_affiliation_strings":["Authors' Affiliations:\u20081Department of Molecular Biology and Biochemistry and Institute for Immunology, University of California, Irvine, Irvine, California, and 2Intellikine, La Jolla, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Department of Molecular Biology and Biochemistry and Institute for Immunology, University of California, Irvine, Irvine, California, and 2Intellikine, La Jolla, California","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059938229","display_name":"Christian Rommel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christian Rommel","raw_affiliation_strings":["Authors' Affiliations:\u20081Department of Molecular Biology and Biochemistry and Institute for Immunology, University of California, Irvine, Irvine, California, and 2Intellikine, La Jolla, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Department of Molecular Biology and Biochemistry and Institute for Immunology, University of California, Irvine, Irvine, California, and 2Intellikine, La Jolla, California","institution_ids":["https://openalex.org/I204250578"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I204250578"],"apc_list":null,"apc_paid":null,"fwci":2.6023,"has_fulltext":false,"cited_by_count":144,"citation_normalized_percentile":{"value":0.92891986,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"1","issue":"7","first_page":"562","last_page":"572"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.5454000234603882,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.5454000234603882,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.4447999894618988,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pi3kdelta-inhibitor","display_name":"PI3K\u03b4 inhibitor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/idelalisib","display_name":"idelalisib","score":0.9710000157356262},{"id":"https://openalex.org/keywords/pi3k-isoform-selectivity","display_name":"PI3K isoform selectivity","score":0.8610000014305115},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.875},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.8370000123977661},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.8679999709129333},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9909999966621399},{"id":"https://openalex.org/keywords/leukemia-microenvironment","display_name":"leukemia microenvironment","score":0.5},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7429999709129333}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.7275986671447754},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.5698965787887573},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4974382221698761},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4780343472957611},{"id":"https://openalex.org/C53345823","wikidata":"https://www.wikidata.org/wiki/Q5531554","display_name":"Gene isoform","level":3,"score":0.47278451919555664},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46763041615486145},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4625588655471802},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4394494593143463},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4229079484939575},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4113272428512573},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39274391531944275},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.39216727018356323},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32793331146240234},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3270595371723175},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3252601623535156},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2893921136856079},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.19829905033111572},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1928553581237793},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.16191178560256958},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1341639757156372},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10618716478347778},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000081082","descriptor_name":"Phosphoinositide-3 Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D052999","descriptor_name":"Quinazolinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D052999","descriptor_name":"Quinazolinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/2159-8290.cd-11-0249","doi":"https://doi.org/10.1158/2159-8290.cd-11-0249","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2159-8290.cd-11-0249","pdf_url":null,"source":{"id":"https://openalex.org/S2486275289","display_name":"Cancer Discovery","issn_l":"2159-8274","issn":["2159-8274","2159-8290"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Discovery","raw_type":"journal-article"},{"id":"pmid:22586681","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22586681","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer discovery","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":113,"referenced_works":["https://openalex.org/W25302644","https://openalex.org/W57072567","https://openalex.org/W67920867","https://openalex.org/W69869516","https://openalex.org/W1481756857","https://openalex.org/W1493876987","https://openalex.org/W1525326448","https://openalex.org/W1541596409","https://openalex.org/W1552927675","https://openalex.org/W1559107951","https://openalex.org/W1595612667","https://openalex.org/W1617435269","https://openalex.org/W1759167934","https://openalex.org/W1797700808","https://openalex.org/W1867136150","https://openalex.org/W1875701681","https://openalex.org/W1969292035","https://openalex.org/W1969438318","https://openalex.org/W1971525986","https://openalex.org/W1978981032","https://openalex.org/W1979816280","https://openalex.org/W1981711832","https://openalex.org/W1982070877","https://openalex.org/W1982905137","https://openalex.org/W1984147944","https://openalex.org/W1984158636","https://openalex.org/W1986835641","https://openalex.org/W1987642183","https://openalex.org/W1988864736","https://openalex.org/W1991761103","https://openalex.org/W1992572858","https://openalex.org/W1996112599","https://openalex.org/W1998836974","https://openalex.org/W2001999652","https://openalex.org/W2005529016","https://openalex.org/W2006771504","https://openalex.org/W2007886976","https://openalex.org/W2008065206","https://openalex.org/W2009886463","https://openalex.org/W2010038061","https://openalex.org/W2010729236","https://openalex.org/W2012346684","https://openalex.org/W2012751406","https://openalex.org/W2018343427","https://openalex.org/W2024523289","https://openalex.org/W2024676945","https://openalex.org/W2025786205","https://openalex.org/W2027971058","https://openalex.org/W2034691869","https://openalex.org/W2038053631","https://openalex.org/W2041706856","https://openalex.org/W2045907249","https://openalex.org/W2046905172","https://openalex.org/W2052763184","https://openalex.org/W2054607545","https://openalex.org/W2056242938","https://openalex.org/W2056854155","https://openalex.org/W2057370954","https://openalex.org/W2057403210","https://openalex.org/W2059256620","https://openalex.org/W2066138756","https://openalex.org/W2068604152","https://openalex.org/W2069545269","https://openalex.org/W2070361307","https://openalex.org/W2070942879","https://openalex.org/W2073391367","https://openalex.org/W2075291089","https://openalex.org/W2075647074","https://openalex.org/W2077223675","https://openalex.org/W2078948501","https://openalex.org/W2081457656","https://openalex.org/W2085483616","https://openalex.org/W2087012714","https://openalex.org/W2087676185","https://openalex.org/W2087693130","https://openalex.org/W2090940799","https://openalex.org/W2093262780","https://openalex.org/W2094312280","https://openalex.org/W2094709780","https://openalex.org/W2097302710","https://openalex.org/W2100458159","https://openalex.org/W2104683328","https://openalex.org/W2109099165","https://openalex.org/W2113343850","https://openalex.org/W2117692326","https://openalex.org/W2118073504","https://openalex.org/W2119374469","https://openalex.org/W2121510983","https://openalex.org/W2121945278","https://openalex.org/W2123666692","https://openalex.org/W2124593509","https://openalex.org/W2129172946","https://openalex.org/W2134123784","https://openalex.org/W2140254135","https://openalex.org/W2143695256","https://openalex.org/W2143900459","https://openalex.org/W2154608911","https://openalex.org/W2154692501","https://openalex.org/W2162003888","https://openalex.org/W2163577434","https://openalex.org/W2164932894","https://openalex.org/W2165742826","https://openalex.org/W2166470267","https://openalex.org/W2166848534","https://openalex.org/W2170938416","https://openalex.org/W2171095731","https://openalex.org/W2242208648","https://openalex.org/W2388163742","https://openalex.org/W2520051342","https://openalex.org/W4243559800","https://openalex.org/W6601000792","https://openalex.org/W6602777516","https://openalex.org/W6633426569"],"related_works":["https://openalex.org/W2398183597","https://openalex.org/W2560799488","https://openalex.org/W2242208648","https://openalex.org/W2025786205","https://openalex.org/W1976522626","https://openalex.org/W2019325963","https://openalex.org/W2590636514","https://openalex.org/W2129900110","https://openalex.org/W2248918524","https://openalex.org/W2555761459"],"abstract_inverted_index":{"UNLABELLED:":[0],"Several":[1],"phosphoinositide":[2],"3-kinase":[3],"(PI3K)":[4],"inhibitors":[5],"are":[6,13],"in":[7,14,29,40,60,75,98,124,151,155],"the":[8,22,43,66,82,134,159],"clinic":[9],"and":[10,72,102],"many":[11],"more":[12],"preclinical":[15],"development.":[16],"CAL-101,":[17],"a":[18,37,76,113,139],"selective":[19,145],"inhibitor":[20],"of":[21,45,49,84,90,133,147],"PI3K\u03b4":[23,34,148],"isoform,":[24],"has":[25,54],"shown":[26],"remarkable":[27],"success":[28],"certain":[30],"hematologic":[31],"malignancies.":[32],"Although":[33],"signaling":[35],"plays":[36],"central":[38],"role":[39],"lymphocyte":[41],"biology,":[42],"degree":[44],"single-agent":[46],"therapeutic":[47],"activity":[48],"CAL-101":[50,58,87,136],"during":[51],"early-phase":[52],"development":[53],"been":[55],"somewhat":[56],"unexpected.":[57],"works":[59],"part":[61,156],"by":[62,142],"blocking":[63],"signals":[64],"from":[65],"microenvironment":[67],"that":[68,92,127,144],"normally":[69],"sustain":[70],"leukemia":[71],"lymphoma":[73],"cells":[74,126],"protective":[77],"niche.":[78],"As":[79],"PI3Ks":[80],"enter":[81],"arena":[83],"molecular-targeted":[85],"therapies,":[86],"provides":[88],"proof":[89],"principle":[91],"isoform-selective":[93],"compounds":[94,111],"can":[95,118],"be":[96],"effective":[97],"selected":[99],"cancer":[100,125],"types":[101],"patient":[103],"populations.":[104],"SIGNIFICANCE:":[105],"A":[106],"key":[107],"question":[108],"is":[109],"whether":[110],"targeting":[112,146,158],"single":[114,121],"PI3K":[115],"catalytic":[116],"isoform":[117],"provide":[119],"meaningful":[120],"agent":[122],"efficacy":[123,150],"express":[128],"multiple":[129],"isoforms.":[130],"Clinical":[131],"studies":[132],"drug":[135],"have":[137],"provided":[138],"significant":[140],"advance":[141],"showing":[143],"achieves":[149],"chronic":[152],"lymphocytic":[153],"leukemia,":[154],"through":[157],"tumor":[160],"microenvironment.":[161]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2145517536","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":15},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":17},{"year":2014,"cited_by_count":21},{"year":2013,"cited_by_count":21},{"year":2012,"cited_by_count":16}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
